{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:06:35Z","timestamp":1790820395855,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec><jats:title>OBJECTIVES:<\/jats:title><jats:p>Sepsis-acquired immunosuppression may play a major role in patients\u2019 prognosis through increased risk of secondary infections. Triggering receptor expressed on myeloid cells 1 (TREM-1) is an innate immune receptor involved in cellular activation. Its soluble form (sTREM-1) has been described as a robust marker of mortality in sepsis. The objective of this study was to evaluate its association with the occurrence of nosocomial infections alone or in combination with human leucocyte antigen-DR on monocytes (mHLA-DR).<\/jats:p><\/jats:sec><jats:sec><jats:title>DESIGN:<\/jats:title><jats:p>Observational study.<\/jats:p><\/jats:sec><jats:sec><jats:title>SETTING:<\/jats:title><jats:p>University Hospital in France.<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS:<\/jats:title><jats:p>One hundred sixteen adult septic shock patients as a post hoc study from the IMMUNOSEPSIS cohort (NCT04067674).<\/jats:p><\/jats:sec><jats:sec><jats:title>INTERVENTIONS:<\/jats:title><jats:p>None.<\/jats:p><\/jats:sec><jats:sec><jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title><jats:p>Plasma sTREM-1 and monocyte HLA-DR were measured at day 1 or 2 (D1\/D2), D3\/D4, and D6\/D8 after admission. Associations with nosocomial infection were evaluated through multivariable analyses. At D6\/D8, both markers were combined, and association with increased risk of nosocomial infection was evaluated in the subgroup of patients with most deregulated markers in a multivariable analysis with death as a competing risk. Significantly decreased mHLA-DR at D6\/D8 and increased sTREM-1 concentrations were measured at all time points in nonsurvivors compared with survivors. Decreased mHLA-DR at D6\/D8 was significantly associated with increased risk of secondary infections after adjustment for clinical parameters with a subdistribution hazard ratio of 3.61 (95% CI, 1.39\u20139.34;<jats:italic toggle=\"yes\">p<\/jats:italic>= 0.008). At D6\/D8, patients with persistently high sTREM-1 and decreased mHLA-DR presented with a significantly increased risk of infection (60%) compared with other patients (15.7%). This association remained significant in the multivariable model (subdistribution hazard ratio [95% CI], 4.65 [1.98\u201310.9];<jats:italic toggle=\"yes\">p<\/jats:italic>&lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>In addition to its prognostic interest on mortality, sTREM-1, when combined with mHLA-DR, may help to better identify immunosuppressed patients at risk of nosocomial infections.<\/jats:p><\/jats:sec>","DOI":"10.1097\/cce.0000000000000869","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T18:00:10Z","timestamp":1677261610000},"page":"e0869","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Persistently Elevated Soluble Triggering Receptor Expressed on Myeloid Cells 1 and Decreased Monocyte Human Leucocyte Antigen DR Expression Are Associated With Nosocomial Infections in Septic Shock Patients"],"prefix":"10.1097","volume":"5","author":[{"given":"Matthieu","family":"Venet","sequence":"first","affiliation":[{"name":"Hospices Civils de Lyon, Edouard Herriot Hospital, Anesthesia and Critical Care Medicine Department, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bidar","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Edouard Herriot Hospital, Anesthesia and Critical Care Medicine Department, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Derive","sequence":"additional","affiliation":[{"name":"Inotrem SA, Vandoeuvre-les-Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Delwarde","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Edouard Herriot Hospital, Anesthesia and Critical Care Medicine Department, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Monard","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Edouard Herriot Hospital, Anesthesia and Critical Care Medicine Department, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Hengy","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Edouard Herriot Hospital, Anesthesia and Critical Care Medicine Department, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Jolly","sequence":"additional","affiliation":[{"name":"Inotrem SA, Vandoeuvre-les-Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rimmel\u00e9","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Edouard Herriot Hospital, Anesthesia and Critical Care Medicine Department, Lyon, France."},{"name":"EA 7426 \u201cPathophysiology of Injury-Induced Immunosuppression\u201d (Universite\u0301 Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMe\u0301rieux), Joint Research Unit HCL-bioMe\u0301rieux, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Lukaszewicz","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Edouard Herriot Hospital, Anesthesia and Critical Care Medicine Department, Lyon, France."},{"name":"EA 7426 \u201cPathophysiology of Injury-Induced Immunosuppression\u201d (Universite\u0301 Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMe\u0301rieux), Joint Research Unit HCL-bioMe\u0301rieux, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[{"name":"EA 7426 \u201cPathophysiology of Injury-Induced Immunosuppression\u201d (Universite\u0301 Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMe\u0301rieux), Joint Research Unit HCL-bioMe\u0301rieux, Lyon, France."},{"name":"Hospices Civils de Lyon, Edouard Herriot Hospital, Immunology Laboratory, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Venet","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Edouard Herriot Hospital, Immunology Laboratory, Lyon, France."},{"name":"Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supe\u0301rieure de Lyon, Universite\u0301 Claude Bernard-Lyon 1, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021.","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study.","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: Results from an updated and expanded systematic review and meta-analysis.","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach.","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis.","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2119\/2007-00102.Monneret","article-title":"Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony.","volume":"14","author":"Monneret","year":"2008","journal-title":"Mol Med"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2016.2691","article-title":"Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis.","volume":"315","author":"van Vught","year":"2016","journal-title":"JAMA"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200609-1322OC","article-title":"Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation.","volume":"175","author":"Luyt","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2008.697","article-title":"Cytomegalovirus reactivation in critically ill immunocompetent patients.","volume":"300","author":"Limaye","year":"2008","journal-title":"JAMA"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrneph.2017.165","article-title":"Advances in the understanding and treatment of sepsis-induced immunosuppression.","volume":"14","author":"Venet","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1164\/rccm.201301-0036CP","article-title":"Immunotherapy for the adjunctive treatment of sepsis: From immunosuppression to immunostimulation. Time for a paradigm change?","volume":"187","author":"Leentjens","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.coi.2013.05.006","article-title":"Monitoring the immune response in sepsis: A rational approach to administration of immunoadjuvant therapies.","volume":"25","author":"Venet","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00134-006-0204-8","article-title":"Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.","volume":"32","author":"Monneret","year":"2006","journal-title":"Intensive Care Med"},{"key":"R15-20240807","first-page":"2746","article-title":"Monocytic HLA-DR expression in intensive care patients: Interest for prognosis and secondary infection prediction.","volume":"37","author":"Lukaszewicz","year":"2009","journal-title":"Crit Care Med"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","article-title":"Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.","volume":"164","author":"Bouchon","year":"2000","journal-title":"J Immunol"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/35074114","article-title":"TREM-1 amplifies inflammation and is a crucial mediator of septic shock.","volume":"410","author":"Bouchon","year":"2001","journal-title":"Nature"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jmb.2004.07.089","article-title":"Crystal structure of human triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.47 A.","volume":"342","author":"Kelker","year":"2004","journal-title":"J Mol Biol"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0312145","article-title":"TREM-1: Intracellular signaling pathways and interaction with pattern recognition receptors.","volume":"93","author":"Arts","year":"2013","journal-title":"J Leukoc Biol"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.imbio.2008.07.008","article-title":"From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection.","volume":"213","author":"Sharif","year":"2008","journal-title":"Immunobiology"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.imlet.2007.11.021","article-title":"The TREM-1\/DAP12 pathway.","volume":"116","author":"Tessarz","year":"2008","journal-title":"Immunol Lett"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.4049\/jimmunol.170.7.3812","article-title":"A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response.","volume":"170","author":"Bleharski","year":"2003","journal-title":"J Immunol"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1189\/jlb.1205758","article-title":"Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors.","volume":"80","author":"Netea","year":"2006","journal-title":"J Leukoc Biol"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41423-018-0003-5","article-title":"TREM-1 multimerization is essential for its activation on monocytes and neutrophils.","volume":"16","author":"Carrasco","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.4049\/jimmunol.179.6.4065","article-title":"Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes.","volume":"179","author":"G\u00f3mez-Pi\u00f1a","year":"2007","journal-title":"J Immunol"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/s41423-021-00733-5","article-title":"sTREM-1 is a specific biomarker of TREM-1 pathway activation.","volume":"18","author":"Jolly","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s00134-005-2572-x","article-title":"Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock.","volume":"31","author":"Gibot","year":"2005","journal-title":"Intensive Care Med"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s12879-016-1893-4","article-title":"Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis.","volume":"16","author":"Charles","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13613-019-0600-1","article-title":"Prediction of mortality in adult patients with sepsis using six biomarkers: A systematic review and meta-analysis.","volume":"9","author":"Pregernig","year":"2019","journal-title":"Ann Intensive Care"},{"key":"R30-20240807","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/1354750X.2016.1204005","article-title":"Soluble TREM-1 as a diagnostic and prognostic biomarker in patients with septic shock: An observational clinical study.","volume":"22","author":"Brenner","year":"2017","journal-title":"Biomarkers"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"105074","DOI":"10.1016\/j.meegid.2021.105074","article-title":"Diagnostic and prognostic predictive values of circulating sTREM-1 in sepsis: A meta-analysis.","volume":"96","author":"Qin","year":"2021","journal-title":"Infect Genet Evol"},{"key":"R32-20240807","doi-asserted-by":"crossref","first-page":"e010314","DOI":"10.1136\/bmjopen-2015-010314","article-title":"Role of sTREM-1 in predicting mortality of infection: A systematic review and meta-analysis.","volume":"6","author":"Su","year":"2016","journal-title":"BMJ Open"},{"key":"R33-20240807","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cyto.b.21043","article-title":"Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples.","volume":"84","author":"Demaret","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"key":"R34-20240807","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cyto.b.21987","article-title":"A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials.","volume":"100","author":"Quadrini","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"key":"R35-20240807","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"JASA"},{"key":"R36-20240807","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00005-017-0499-x","article-title":"Soluble TREM-1 serum level can early predict mortality of patients with sepsis, severe sepsis and septic shock.","volume":"66","author":"Jedynak","year":"2018","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"R37-20240807","doi-asserted-by":"crossref","first-page":"99","DOI":"10.31053\/1853.0605.v74.n2.14608","article-title":"IL-6, MMP 3 and prognosis in previously healthy sepsis patients.","volume":"74","author":"Ricarte-Bratti","year":"2017","journal-title":"Rev Fac Cien Med Univ Nac Cordoba"},{"key":"R38-20240807","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF01712155","article-title":"Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock.","volume":"22","author":"Marecaux","year":"1996","journal-title":"Intensive Care Med"},{"key":"R39-20240807","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/EJA.0b013e328329afca","article-title":"Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation.","volume":"26","author":"Bopp","year":"2009","journal-title":"Eur J Anaesthesiol"},{"key":"R40-20240807","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1084\/jem.20111354","article-title":"A genomic storm in critically injured humans.","volume":"208","author":"Xiao","year":"2011","journal-title":"J Exp Med"},{"key":"R41-20240807","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy.","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R42-20240807","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1213\/ane.0b013e318195e11d","article-title":"Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis.","volume":"108","author":"Torgersen","year":"2009","journal-title":"Anesth Analg"},{"key":"R43-20240807","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12879-020-05196-z","article-title":"Significance of sTREM-1 in early prediction of ventilator-associated pneumonia in neonates: A single-center, prospective, observational study.","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R44-20240807","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MPG.0b013e3182294fcc","article-title":"sTREM-1 and LBP in central venous catheter-associated bloodstream infections in pediatric intestinal failure.","volume":"53","author":"Kevan","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R45-20240807","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/CCM.0000000000005270","article-title":"Immune profiling demonstrates a common immune signature of delayed acquired immunodeficiency in patients with various etiologies of severe injury.","volume":"50","author":"Venet","year":"2022","journal-title":"Crit Care Med"},{"key":"R46-20240807","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13613-022-01051-3","article-title":"A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: The REALIST score.","volume":"12","author":"Tremblay","year":"2022","journal-title":"Ann Intensive Care"},{"key":"R47-20240807","doi-asserted-by":"crossref","first-page":"e33095","DOI":"10.1371\/journal.pone.0033095","article-title":"Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: A powerful association to predict the development of sepsis after major trauma.","volume":"7","author":"Gouel-Ch\u00e9ron","year":"2012","journal-title":"PLoS One"},{"key":"R48-20240807","doi-asserted-by":"crossref","first-page":"e0187088","DOI":"10.1371\/journal.pone.0187088","article-title":"Development and validation of immune dysfunction score to predict 28-day mortality of sepsis patients.","volume":"12","author":"Fang","year":"2017","journal-title":"PLoS One"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T03:52:02Z","timestamp":1728964322000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000869","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]}}}